Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

TABLE 1s. Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents weeks ending February 16, 2019 (week 07)
Reporting Area Invasive pneumococcal disease, all ages §
Confirmed Probable
Current
week
Previous 52
weeks Max †
Cum YTD
2019 †
Cum YTD
2018 †
Current
week
Previous 52
weeks Max †
Cum YTD
2019 †
Cum YTD
2018 †
U.S. Residents, excluding U.S. Territories 190 686 2,510 4,529 5 12 45 53
New England 5 43 69 247 - 2 - 1
Connecticut - 13 3 58 - 0 - -
Maine 5 9 43 27 - 0 - -
Massachusetts - 17 - 117 - 2 - -
New Hampshire - 7 13 25 - 0 - 1
Rhode Island - 10 6 7 - 0 - -
Vermont - 5 4 13 - 1 - -
Middle Atlantic 38 104 380 602 - 4 9 5
New Jersey 1 28 87 151 - 3 8 1
New York (excluding New York City) 18 63 115 155 - 1 1 -
New York City 19 26 143 173 - 2 - -
Pennsylvania - 24 35 123 - 2 - 4
East North Central 34 116 434 706 4 3 15 15
Illinois N NC N N N NC N N
Indiana - 35 53 166 - 0 - -
Michigan 2 37 70 143 - 2 1 6
Ohio 31 68 253 300 4 3 14 9
Wisconsin 1 22 58 97 - 0 - -
West North Central 13 40 169 330 1 6 11 14
Iowa N NC N N N NC N N
Kansas - 12 19 56 - 2 1 2
Minnesota - 3 - 9 - 0 - -
Missouri 6 26 105 192 1 5 7 11
Nebraska 5 7 27 38 - 1 2 1
North Dakota - 5 4 16 - 0 - -
South Dakota 2 6 14 19 - 1 1 -
South Atlantic 35 94 447 771 - 2 4 9
Delaware - 5 8 17 - 0 - -
District of Columbia - 5 7 17 - 0 - -
Florida 17 24 113 152 - 2 2 3
Georgia 10 34 133 258 - 0 - -
Maryland 8 23 80 104 - 1 - 1
North Carolina N NC N N N NC N N
South Carolina - 23 83 151 - 1 2 5
Virginia - 2 3 6 - 1 - -
West Virginia - 11 20 66 - 1 - -
East South Central 2 89 240 549 - 1 2 -
Alabama 1 25 62 139 - 1 - -
Kentucky - 22 69 91 - 1 1 -
Mississippi 1 19 51 78 - 0 - -
Tennessee - 31 58 241 - 1 1 -
West South Central 30 244 322 615 - 2 - 2
Arkansas 11 26 61 75 - 1 - -
Louisiana 4 24 67 141 - 2 - -
Oklahoma N NC N N N NC N N
Texas 15 206 194 399 - 2 - 2
Mountain 31 88 413 671 - 2 1 7
Arizona 10 36 167 257 - 2 - 7
Colorado 16 23 108 174 - 1 - -
Idaho N NC N N N NC N N
Montana - 6 9 24 - 1 - -
Nevada - 13 27 58 - 1 - -
New Mexico 5 18 70 89 - 0 - -
Utah - 9 31 58 - 1 1 -
Wyoming - 3 1 11 - 0 - -
Pacific 2 11 36 38 - 1 3 -
Alaska 2 7 24 18 - 1 3 -
California N NC N N N NC N N
Hawaii - 5 12 20 - 0 - -
Oregon N NC N N N NC N N
Washington N NC N N N NC N N
U.S. Territories - 0 - - - 0 - -
American Samoa N NC N N N NC N N
Commonwealth of Northern Mariana Islands - 0 - - - 0 - -
Guam - 0 - - - 0 - -
Puerto Rico - 0 - - - 0 - -
U.S. Virgin Islands - 0 - - - 0 - -
Non-U.S. Residents - NC - NP - NC - NP
Total 190 686 2,510 4,529 5 12 45 53
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • Max: Maximum — Maximum case count during the previous 52 weeks.
  • * Case counts for reporting years 2018 and 2019 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.
  • †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.